生物活性 | |||
---|---|---|---|
描述 | Ralaniten, also known as EPI-002, is a potent, orally active AR-NTD antagonist. Ralaniten inhibits the transcriptional activity of AR with an IC50 value of 7.4 μM. Ralaniten can be used to study castration-resistant prostate cancer (CRPC)[1][2].At concentrations of 5-35 μM for 2-3 days, Ralaniten reduced AR-dependent proliferation of LNCaP cells, but had no effect on the survival of PC3 human prostate cancer cells that do not express functional AR[1][2].Ralaniten inhibited forskolin-induced AR-NTD transcription in LNCaP cells at concentrations of 10-35 μM for 4 hours of action[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.53mL 0.51mL 0.25mL |
12.66mL 2.53mL 1.27mL |
25.32mL 5.06mL 2.53mL |
参考文献 |
---|